Skip to content
Recall Observatory FDA recall evidence

Drug product

Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale -Bardez, Goa 403513, India, Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-295-01

D-1095-2023

August 14, 2023

Class III

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 92859
Status
Ongoing
Classification
Class III
Quantity
1,200 bottles
Official record key
drug-enforcement:D-1095-2023

Official wording

Reason: Subpotent: Out of Specification for Assay Test at the 3-month time point.

Code information: Batch # 19224744

Distribution pattern: nationwide in the U.S.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent